Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. HRTS: which is better?

Bottom line

FHLC vs HRTS: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 59% by weight.

But FHLC is far broader, holding 337 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.

FHLC is cheaper at 0.084% vs 0.75% — a difference of $67 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +2.6% for FHLC (reporting dates differ).

Updated Nov 19, 2026

FHLC vs HRTS side by side

FHLCHRTS
TypeETFETF
Fund familyFidelityInnovator
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%0.75%
Annual cost per $10k$8.4$75
10-yr cost on $10k (prospectus)$108$1,168
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+2.6%+23.6%
5-yr return (annualized)+7.2%—
10-yr return (annualized)+8.8%—
Best quarter+16.4%+15.8%
Worst quarter−13.1%−12.4%
Net assets (fund)$3.3B$51.9M
Number of holdings33745
Portfolio turnover3%4%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCHRTSDifference
2024+2.6%+3.6%−1.0%

Source: Fund prospectus bar charts

Holdings overlap

15 of FHLC's top 25 holdings also appear in HRTS's top 25.

Shared top holdings
HoldingFHLCHRTS
Eli Lilly & Co13.35%11.52%
Johnson & Johnson8.93%3.59%
AbbVie Inc6.42%2.40%
UnitedHealth Group Inc5.44%5.24%
Merck & Co Inc4.66%4.27%
Thermo Fisher Scientific Inc3.09%3.97%
Amgen Inc3.00%1.91%
Abbott Laboratories2.66%2.61%
Gilead Sciences Inc2.34%3.43%
Bristol-Myers Squibb Co1.93%2.09%
Danaher Corp1.80%2.66%
Vertex Pharmaceuticals Inc1.76%2.93%
Medtronic PLC1.59%1.88%
McKesson Corp1.52%1.71%
Regeneron Pharmaceuticals Inc1.15%1.67%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

FAQ

What is the difference between FHLC and HRTS?
FHLC (Fidelity MSCI Health Care Index ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 59% by weight. But FHLC is far broader, holding 337 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
Which is cheaper, FHLC or HRTS?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.